1. Home
  2. AGEN vs SUNS Comparison

AGEN vs SUNS Comparison

Compare AGEN & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.38

Market Cap

126.2M

Sector

Health Care

ML Signal

HOLD

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$8.03

Market Cap

126.3M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGEN
SUNS
Founded
1994
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
126.2M
126.3M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
AGEN
SUNS
Price
$3.38
$8.03
Analyst Decision
Buy
Hold
Analyst Count
2
1
Target Price
$14.50
$8.75
AVG Volume (30 Days)
486.5K
91.1K
Earning Date
03-16-2026
03-12-2026
Dividend Yield
N/A
14.87%
EPS Growth
100.00
N/A
EPS
N/A
N/A
Revenue
$42,877,086.00
N/A
Revenue This Year
$61.42
$91.00
Revenue Next Year
N/A
$20.79
P/E Ratio
$8.89
$8.84
Revenue Growth
89.95
N/A
52 Week Low
$1.38
$7.80
52 Week High
$7.34
$11.78

Technical Indicators

Market Signals
Indicator
AGEN
SUNS
Relative Strength Index (RSI) 49.59 28.53
Support Level $2.91 N/A
Resistance Level $4.72 $9.69
Average True Range (ATR) 0.27 0.27
MACD -0.01 -0.06
Stochastic Oscillator 38.97 4.58

Price Performance

Historical Comparison
AGEN
SUNS

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

Share on Social Networks: